Jubilant Ingrevia Limited convened a Board of Directors meeting on October 27, 2026, as per an exchange filing submitted to the NSE at 14:04 hours. The announcement, classified as an outcome of a board meeting, follows the company's established cadence of mid-year board reviews and comes against the backdrop of a well-documented dividend payment history stretching back to its early years as a listed entity.

Dividend Structure and Recent Payouts

Jubilant Ingrevia has maintained a consistent two-tranche dividend structure in recent fiscal years, combining an interim dividend declared in January or February with a final dividend recommended in May. For FY2026, the company declared an interim dividend of ₹2.50 per equity share on February 4, 2026, and followed it with a recommended final dividend of ₹2.50 per equity share on May 26, 2026, bringing the total payout for FY2026 to ₹5.00 per equity share.

This mirrors the FY2025 pattern exactly, where an interim dividend of ₹2.50 per share was declared on January 28, 2025, and a final dividend of ₹2.50 per share was recommended on May 13, 2025, again totalling ₹5.00 per equity share for the year.

Dividend History: A Pattern of Consistency

The company's dividend record since listing reflects a structured and unchanged per-share payout policy:

The data reveals that Jubilant Ingrevia has held its per-share dividend amount flat at ₹2.50 per tranche without a single revision since FY2022. There has been no dividend growth in absolute per-share terms over this five-year period, which investors should factor into their income-return assessments.

Company Background

Jubilant Ingrevia Limited is a specialty chemicals company demerged from Jubilant Life Sciences. It operates across three business segments: specialty chemicals, nutrition ingredients, and chemical intermediates. The company supplies to global pharmaceuticals, agrochemicals, and nutrition end-markets. Its equity shares are listed on both NSE and BSE under the symbol JUBLINGREA with ISIN INE0BY001018.

What the Data Indicates for Investors

With market price and trade data unavailable at the time of this filing, a precise dividend yield calculation cannot be published. However, investors tracking the stock should note that the total annual dividend of ₹5.00 per share has remained unchanged for at least four consecutive fiscal years. The absence of dividend growth, even as the company continued dual-tranche payouts, suggests a conservative and formulaic capital return policy rather than an earnings-linked payout progression.

The October 27 board meeting outcome, once fully disclosed, may carry additional financial updates including quarterly results for the period ending September 2026. Investors should monitor the detailed outcome filing for specifics on earnings, margins, or any revision to the company's capital allocation policy.